awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q50092012-28AE78E4-60E4-4F75-A10C-2BA3E675BB27
Q50092012-28AE78E4-60E4-4F75-A10C-2BA3E675BB27
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50092012-28AE78E4-60E4-4F75-A10C-2BA3E675BB27
Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide.
P2093
Q50092012-28AE78E4-60E4-4F75-A10C-2BA3E675BB27
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50092012-28AE78E4-60E4-4F75-A10C-2BA3E675BB27
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c7e189f6e5c953affcd546265b98c45eeed49715
P1545
20
http://www.w3.org/2001/XMLSchema#string
P2093
Ruben Mesa
http://www.w3.org/2001/XMLSchema#string